Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
283.64-7.25 (-2.49%)
At close: 4:00 PM EDT

283.64 0.00 (0.00%)
After hours: 5:07 PM EDT

People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close290.89
Bid282.00 x 200
Ask288.00 x 100
Day's Range280.35 - 290.47
52wk Range223.02 - 333.65
1y Target EstN/A
Market Cap62.15B
P/E Ratio (ttm)16.04
Avg Vol (3m)1,570,933
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Market Realist18 minutes ago

    Tysabri Continues to Witness Strong Growth in 3Q16

    In 3Q16, Biogen’s multiple sclerosis franchise managed to earn revenue of $2.3 billion, a year-over-year (or YoY) rise of ~3% and a sequential rise of ~2%.

  • Market Realist1 hour ago

    Tecfidera Continued to Lead in the Oral Multiple Sclerosis Market

    In 3Q16, Biogen’s (BIIB) oral multiple sclerosis (or MS) drug, Tecfidera, managed to increase its global market share to ~15%, a year-over-year (or YoY) rise of about 1 point.

  • Capital Cube4 hours ago

    ETF’s with exposure to Biogen, Inc. : October 28, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Biogen, Inc. Here are 5 ETF’s with the largest exposure to BIIB-US. Comparing the performance and risk of Biogen, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)